Advanced Search

Submit Online

Research Highlights

< Previous         Next >  
Acute lung injury: a yellow card for engineered nanoparticles? Free
Mingyao Liu1,2,3,*, Haibo Zhang3,4,5, and Arthur S. Slutsky2,3,5
1 Latner Thoracic Surgery Research Laboratories, Toronto General Research Institute, University Health Network, Toronto, ON, Canada
2 Department of Surgery, Faculty of Medicine, University of Toronto, Toronto, ON, Canada
3Department of Medicine, Faculty of Medicine, University of Toronto, Toronto, ON, Canada
4Department of Anaesthesia, Faculty of Medicine, University of Toronto, Toronto, ON, Canada
5The Keenan Research Centre, Li Ka Shing Knowledge Institute of St. Michael's Hospital, Toronto, ON, Canada *Correspondence to:Mingyao Liu, Tel: +1-416-581-7501; Fax: +1-416-581-7504; E-mail: mingyao.liu@utoronto.ca
J Mol Cell Biol, Volume 1, Issue 1, October 2009, 6-7,  https://doi.org/10.1093/jmcb/mjp006

Application of nanomaterials in various diagnostic and therapeutic areas shows great promise. To translate nanotechnology into nanomedicine, it is important to understand any potential mechanisms of toxicity caused by nanomaterials, and to design approaches to mitigate any detrimental effects.

Volume 1, Issue 1
October 2009